Cory Watson, P.C. - Firm Profile
Cory Watson, P.C.
Size of Organization: 13
|Profile Visibility |
#10,039 in weekly profile views out of 280,573 total law firms Overall
Cory, Watson, Crowder & DeGaris, P.C. dedicates its efforts to the practice of complex civil litigation, representing individuals and classes throughout the United States. The areas of practice include product liability, toxic torts, pharmaceutical and medical device litigation, business litigation, insurance law, tax shelter litigation and aviation accidents. In the realm of class actions, mass torts and multidistrict litigation, members of the firm have over twenty years of experience, and have been appointed by courts across the country to serve as class counsel and assume management positions including, most recently, In Re Chantix (Varenicline) Products Liability Litigation, MDL No. 2092 (Plaintiff's Lead Counsel); In Re Oral Sodium Phosphate Solution-Based Products Liability Litigation (Fleet) MDL 2066 (Plaintiff's Steering Committee); In Re Yamaha Motor Corp. ATV Products Liability Litigation, MDL No. 2116 (Plaintiff's Executive Committee); In re ProtoGen Pubovaginal Sling Products Liability Litigation, MDL No. 1387 (Plaintiff's Head Counsel); In Re Fosamax Products Liability Litigation, MDL No. 1789 (Plaintiff's Management Committee), In Re Bausch & Lomb Inc. Contact Lens Solution Products Liability Litigation, MDL No. 1785 (Plaintiff's Management Committee); and, Denny v. Jenkens & Gilchrist, et al., U.S.D.C. Southern District of N.Y., Case No. 03-CV-5460 (Co-Class Counsel), In Re Kugel Mesh Hernia Mesh Patches Products Liability Litigation, MDL 1842 (Plaintiff's Co-Lead Counsel and Chairman of Plaintiff's Discovery Committee), In Re Con Agra Products Liability Litigation, MDL 1847 (Plaintiff's Steering Committee and Co-Chairman Plaintiff's Discovery Committee), In Re High Sulfur Content Gasoline Products Liability Litigation, MDL 1632 (Plaintiff's Co-Lead Counsel and Plaintiff's Steering Committee), In Re Bextra Products Liability Litigation, MDL 1699 (Plaintiff's Steering Committee), In Re Trasylol Products Liability Litigation, MDL 1928 (Plaintiff's Steering Committee).The firm has represented thousands of clients in litigation arising from the sale and marketing of dangerous and defective pharmaceuticals and medical devices in the United States, including Baycol, Bextra, Celebrex, Chantix, FenPhen Diet Drug, Hormone Therapy, Ortho Evra, Phenylpropanolamine, Propulsid, Ace Inhibitors for increased risk of first trimester birth defects; Bausch & Lombs ReNu MoistureLoc Contact Lens Solution for increased risk of severe eye infections; Fosamax for increased risk of a vascular necrosis; Ketek for increased risk of acute liver failure, Knee Joint recalls; Kugel Mesh Hernia Patches recalled for fractures in the device; Lead Paint poisoning of children; Medtronic Sprint Fidelis cardiac fractured lead wires; Peter Pan Peanut Butter recalled for salmonella contamination, Protegen Vaginal Sling recalled for urethral-genital infections; Trasylol for increased risk of renal failure; and Vioxx, and Yamaha Rhino rollovers. The firm has an equally extensive practice in individual personal injury and wrongful death cases covering motor vehicle collisions; railroad grade crossing accidents, defective automobiles, trucks, and ATVs; automobile crashworthiness, toxic exposures; water, soil and noise pollution; roadway construction failures; workplace and construction site accidents; building and structure failures; dangerous household products including heaters, cooking appliances and tools, and insurance and consumer lending fraud.
Statement of Practice Summary:
Contaminated IV Deaths; Auto Accidents; Aviation Accidents; Brain Injury; Class Actions; Consumer Litigation; Consumer Fraud; Defective Building Design; Defective Highway Design; Defective Medical Device; Defective Product; Environmental Law; Fire & Burn Injury; Motorcycle Accidents; Truck Accidents; Workplace Accidents; Wrongful Death.